Free tool
Healthcare stocks
We cover 1,001 companies in the Healthcare sector. The median market value in the group is $662.22M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is +0.49%. 56% of the 965 with a 200-day average trade above it. Price change over the past year runs from −40.3% to +124.3% across the middle 80 percent of the group, with a median of +9.6%. Among those 1,000, 6 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,001 of 2,199 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.85% |
| GILD34.SA | Gilead Sciences, Inc. | $184.17B | Large cap | −78.95% |
| GIS.DE | Gilead Sciences, Inc. | $183.56B | Large cap | +29.53% |
| PFE.DE | Pfizer Inc. | $162.65B | Large cap | +18.09% |
| PFIZ34.SA | Pfizer Inc. | $161.64B | Large cap | +11.31% |
| PFE | Pfizer Inc. | $159.42B | Large cap | +19.52% |
| DHR | Danaher Corporation | $151.82B | Large cap | +4.52% |
| DHER34.SA | Danaher Corporation | $151.72B | Large cap | −0.75% |
| DAP.DE | Danaher Corporation | $151.41B | Large cap | +5.45% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $140.77B | Large cap | +40.14% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | $140.14B | Large cap | −83.17% |
| VRTX | Vertex Pharmaceuticals Incorporated | $140.04B | Large cap | +42.14% |
| BMY | Bristol-Myers Squibb Company | $138.74B | Large cap | +49.31% |
| BMYB34.SA | Bristol-Myers Squibb Company | $138.65B | Large cap | +40.74% |
| BRM.DE | Bristol-Myers Squibb Company | $138.39B | Large cap | +46.24% |
| IUI1.DE | Intuitive Surgical, Inc. | $133.35B | Large cap | −20.90% |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −20.62% |
| I1SR34.SA | Intuitive Surgical, Inc. | $133.21B | Large cap | −24.38% |
| SYK | Stryker Corporation | $126.81B | Large cap | −14.79% |
| S1YK34.SA | Stryker Corporation | $126.62B | Large cap | −17.50% |
| SYK.DE | STRYKER CORP. R | $126.48B | Large cap | +34.76% |
| MDTC34.SA | Medtronic plc | $117.91B | Large cap | −76.08% |
| 2M6.DE | Medtronic plc | $117.39B | Large cap | +3.67% |
| MDT | Medtronic plc | $116.66B | Large cap | +1.33% |
| SNY | Sanofi | $110.27B | Large cap | −3.11% |
| SAN.PA | Sanofi | $110.15B | Large cap | −4.49% |
| SNW.DE | Sanofi | $109.49B | Large cap | −4.28% |
| MCK | McKesson Corporation | $105.52B | Large cap | +33.71% |
| GS71.DE | GSK plc | $104.54B | Large cap | +31.93% |
| G1SK34.SA | GSK plc | $104.53B | Large cap | +28.14% |
| GSK | GSK plc | $104.29B | Large cap | +34.79% |
| GSK.L | GSK plc | $104.16B | Large cap | +28.03% |
| M1CK34.SA | McKesson Corporation | $101.65B | Large cap | −92.48% |
| HCA | HCA Healthcare, Inc. | $95.12B | Large cap | +6.96% |
| H1CA34.SA | HCA Healthcare, Inc. | $92.89B | Large cap | +3.95% |
| A58.DE | Elevance Health, Inc. | $86.73B | Large cap | −18.92% |
| E1LV34.SA | Elevance Health, Inc. | $86.53B | Large cap | +21.66% |
| ELV | Elevance Health, Inc. | $86.50B | Large cap | +29.17% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $86.30B | Large cap | −7.35% |
| ESL.DE | EssilorLuxottica Société anonyme | $85.86B | Large cap | −38.59% |
| REGN | Regeneron Pharmaceuticals, Inc. | $85.82B | Large cap | +46.21% |
| EL.PA | EssilorLuxottica Société anonyme | $85.41B | Large cap | −37.89% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $85.24B | Large cap | +37.96% |
| CI | The Cigna Group | $73.81B | Large cap | −5.62% |
| C1IC34.SA | The Cigna Group | $73.40B | Large cap | −85.51% |
| CGN.DE | The Cigna Group | $73.25B | Large cap | −8.36% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $73.00B | Large cap | +12.47% |
| B1SX34.SA | Boston Scientific Corporation | $72.28B | Large cap | −88.79% |
| BSX | Boston Scientific Corporation | $72.26B | Large cap | −52.56% |
| BSX.DE | Boston Scientific Corporation | $71.57B | Large cap | −54.21% |
| MRK.DE | Merck KGaA | $70.75B | Large cap | +30.60% |
| ARGX | argenx SE | $63.78B | Large cap | +50.52% |
| M1RN34.SA | Moderna, Inc. | $63.51B | Large cap | +494.34% |
| 0QF.DE | Moderna, Inc. | $63.46B | Large cap | +461.14% |
| MRNA | Moderna, Inc. | $63.41B | Large cap | +526.55% |
| A1RG34.SA | argenx SE | $63.17B | Large cap | +44.49% |
| COR | Cencora, Inc. | $62.60B | Large cap | +14.44% |
| CSL.AX | CSL Limited | $59.98B | Large cap | −17.14% |
| 4502.T | Takeda Pharmaceutical Company Limited | $58.99B | Large cap | +39.50% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +21.77% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | $57.23B | Large cap | +16.07% |
| BAYN.DE | Bayer Aktiengesellschaft | $56.51B | Large cap | +71.10% |
| CAH | Cardinal Health, Inc. | $55.33B | Large cap | +64.25% |
| C1AH34.SA | Cardinal Health, Inc. | $55.24B | Large cap | +50.94% |
| BAY.WA | Bayer Aktiengesellschaft | $55.03B | Large cap | +71.25% |
| 207940.KS | Samsung Biologics Co.,Ltd. | $53.31B | Large cap | +2.60% |
| C1CO34.SA | Cencora, Inc. | $52.36B | Large cap | −12.17% |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.38% |
| BOX.DE | Becton, Dickinson and Company | $52.05B | Large cap | +2.94% |
| EWL.DE | Edwards Lifesciences Corporation | $51.93B | Large cap | +10.23% |
| SHL.DE | Siemens Healthineers AG | $51.88B | Large cap | −12.35% |
| B1DX34.SA | Becton, Dickinson and Company | $51.78B | Large cap | −113.87% |
| BDX | Becton, Dickinson and Company | $51.69B | Large cap | +26.17% |
| 7741.T | HOYA Corporation | $51.57B | Large cap | +29.26% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.24% |
| E1WL34.SA | Edwards Lifesciences Corporation | $47.29B | Large cap | −4.72% |
| MDLN | Medline Inc. | $46.69B | Large cap | −13.07% |
| HUM | Humana Inc. | $46.42B | Large cap | +32.71% |
| H1UM34.SA | Humana Inc. | $45.80B | Large cap | +24.30% |
| RVMD | Revolution Medicines, Inc. | $45.35B | Large cap | +492.60% |
| HLN | Haleon plc | $44.77B | Large cap | +6.56% |
| H6D0.DE | Haleon plc | $44.53B | Large cap | +4.86% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.40B | Large cap | +110.26% |
| HLN.L | Haleon plc | $44.36B | Large cap | +2.08% |
| I1DX34.SA | IDEXX Laboratories, Inc. | $44.35B | Large cap | −16.38% |
| IDXX | IDEXX Laboratories, Inc. | $43.39B | Large cap | −14.24% |
| A | Agilent Technologies, Inc. | $43.33B | Large cap | +30.69% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | $43.18B | Large cap | +94.70% |
| IX1.DE | IDEXX Laboratories, Inc. | $43.12B | Large cap | +17.97% |
| IQV | IQVIA Holdings Inc. | $42.70B | Large cap | +37.97% |
| QTS.DE | IQVIA Holdings Inc. | $42.69B | Large cap | −3.91% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +21.95% |
| V2EE34.SA | Veeva Systems Inc. | $41.01B | Large cap | −16.69% |
| WAT | Waters Corporation | $40.69B | Large cap | +38.63% |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.62B | Large cap | +58.81% |
| VEEV | Veeva Systems Inc. | $40.09B | Large cap | −13.47% |
| VEE.DE | Veeva System Inc. R | $40.06B | Large cap | +13.96% |
| A1GI34.SA | Agilent Technologies, Inc. | $39.64B | Large cap | −77.11% |
| WATC34.SA | Waters Corporation | $36.36B | Large cap | +24.76% |
| ALC | Alcon Inc. | $35.47B | Large cap | −8.71% |
| RPRX | Royalty Pharma plc | $35.44B | Large cap | +75.10% |
| 2U3.DE | Alcon Inc. | $35.35B | Large cap | −10.05% |
| DC4.DE | DexCom, Inc. | $34.19B | Large cap | +21.55% |
| RMD | ResMed Inc. | $34.13B | Large cap | −16.58% |
| I1LM34.SA | Illumina, Inc. | $34.11B | Large cap | +113.13% |
| RMD.AX | ResMed Inc. | $34.05B | Large cap | −24.73% |
| ILU.DE | Illumina, Inc. | $34.04B | Large cap | +119.28% |
| ILMN | Illumina, Inc. | $33.97B | Large cap | +125.76% |
| D1EX34.SA | DexCom, Inc. | $33.83B | Large cap | +11.74% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +17.38% |
| GEHC | GE HealthCare Technologies Inc. | $33.62B | Large cap | −0.78% |
| 4568.T | Daiichi Sankyo Company, Limited | $33.36B | Large cap | −15.95% |
| IDP.DE | Biogen Inc. | $32.80B | Large cap | +57.35% |
| C1NC34.SA | Centene Corporation | $32.65B | Large cap | +116.81% |
| BIIB | Biogen Inc. | $32.62B | Large cap | +61.90% |
| BIIB34.SA | Biogen Inc. | $32.56B | Large cap | +47.86% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −45.88% |
| CNC | Centene Corporation | $32.11B | Large cap | +123.52% |
| ZTS | Zoetis Inc. | $31.94B | Large cap | −49.59% |
| 068270.KS | Celltrion, Inc. | $31.91B | Large cap | +13.47% |
| Z1TS34.SA | Zoetis Inc. | $31.90B | Large cap | −52.14% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | $31.87B | Large cap | −11.75% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $31.78B | Large cap | −49.89% |
| ZOE.DE | Zoetis Inc. | $31.72B | Large cap | −50.09% |
| FRE.DE | Fresenius SE & Co. KGaA | $30.15B | Large cap | +1.55% |
| 22UA.DE | BioNTech SE | $29.53B | Large cap | +8.53% |
| B1NT34.SA | BioNTech SE | $28.89B | Large cap | +3.26% |
| BNTX | BioNTech SE | $28.65B | Large cap | +8.55% |
| MTD | Mettler-Toledo International Inc. | $28.10B | Large cap | +8.72% |
| MTO.DE | Mettler-Toledo International Inc. | $27.84B | Large cap | +13.15% |
| 4503.T | Astellas Pharma Inc. | $27.40B | Large cap | +56.44% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +23.25% |
| R1MD34.SA | ResMed Inc. | $27.30B | Large cap | −38.24% |
| INSM | Insmed Incorporated | $27.07B | Large cap | −3.45% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.70% |
| PHG | Koninklijke Philips N.V. | $26.81B | Large cap | +3.60% |
| PHI1.DE | Koninklijke Philips N.V. | $26.73B | Large cap | +2.84% |
| INCY | Incyte Corporation | $26.29B | Large cap | +53.04% |
| ROIV | Roivant Sciences Ltd. | $26.26B | Large cap | +213.32% |
| I1NC34.SA | Incyte Corporation | $25.83B | Large cap | +41.91% |
| WST | West Pharmaceutical Services, Inc. | $24.52B | Large cap | +41.31% |
| 4543.T | Terumo Corporation | $24.11B | Large cap | −1.19% |
| SIG.AX | Sigma Healthcare Limited | $23.62B | Large cap | −5.33% |
| STE | STERIS plc | $23.05B | Large cap | −4.35% |
| DIM.PA | Sartorius Stedim Biotech S.A. | $22.07B | Large cap | +10.02% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $22.06B | Large cap | +10.46% |
| GH | Guardant Health, Inc. | $21.90B | Large cap | +166.52% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +54.57% |
| GMAB | Genmab A/S | $21.42B | Large cap | +41.34% |
| GE9.DE | GENMAB AS N | $21.11B | Large cap | −14.41% |
| GMAB.CO | Genmab A/S | $21.08B | Large cap | +33.08% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.88B | Large cap | +26.10% |
| S1TE34.SA | STERIS plc | $19.75B | Large cap | −18.78% |
| VTRS | Viatris Inc. | $19.20B | Large cap | +62.88% |
| VIA.DE | Viatris Inc. | $19.14B | Large cap | +62.09% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.12B | Large cap | −5.86% |
| QS51.DE | Straumann Holding AG | $18.25B | Large cap | +0.41% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | $18.07B | Large cap | −5.04% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $17.32B | Large cap | +54.48% |
| MEDP | Medpace Holdings, Inc. | $17.31B | Large cap | +31.55% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +108.87% |
| ASND | Ascendis Pharma A/S | $16.59B | Large cap | +32.89% |
| COLO-B.CO | Coloplast A/S | $16.31B | Large cap | −20.81% |
| CBHD.DE | Coloplast A/S | $16.19B | Large cap | +7.28% |
| IPN.PA | Ipsen S.A. | $16.01B | Large cap | +39.21% |
| BBIO | BridgeBio Pharma, Inc. | $15.85B | Large cap | +70.01% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.80B | Large cap | +13.60% |
| SRT.DE | Sartorius Aktiengesellschaft | $15.72B | Large cap | +22.06% |
| N1BI34.SA | Neurocrine Biosciences, Inc. | $15.69B | Large cap | +7.58% |
| 4507.T | Shionogi & Co., Ltd. | $15.68B | Large cap | +17.95% |
| SOLV | Solventum Corporation | $15.59B | Large cap | +25.92% |
| NBIX | Neurocrine Biosciences, Inc. | $15.59B | Large cap | +14.46% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $15.25B | Large cap | +5.51% |
| C1OO34.SA | The Cooper Companies, Inc. | $15.12B | Large cap | −0.30% |
| ERF.PA | Eurofins Scientific SE | $14.91B | Large cap | +13.76% |
| ESF0.DE | Eurofins Scientific SE | $14.63B | Large cap | +11.02% |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +26.42% |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −0.60% |
| CRL | Charles River Laboratories International, Inc. | $14.21B | Large cap | +81.37% |
| PME.AX | Pro Medicus Limited | $14.09B | Large cap | −38.33% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +49.66% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +35.78% |
| B1AX34.SA | Baxter International Inc. | $13.60B | Large cap | +2.30% |
| BAX | Baxter International Inc. | $13.59B | Large cap | +7.91% |
| ICLR | ICON Public Limited Company | $13.38B | Large cap | −1.65% |
| CORT | Corcept Therapeutics Incorporated | $13.36B | Large cap | +79.56% |
| ORNBV.HE | Orion Oyj | $13.29B | Large cap | +16.59% |
| ORNAV.HE | Orion Oyj | $13.24B | Large cap | +17.12% |
| S1NN34.SA | Smith & Nephew plc | $12.87B | Large cap | −20.44% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.80B | Large cap | +13.03% |
| PEN | Penumbra, Inc. | $12.75B | Large cap | +22.79% |
| FME.DE | Fresenius Medical Care AG | $12.66B | Large cap | −3.50% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.60B | Large cap | +2.09% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | $12.54B | Large cap | +6.36% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +329.16% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.29% |
| R1VT34.SA | Revvity, Inc. | $12.50B | Large cap | +22.81% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +51.39% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −9.45% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | −19.49% |
| ELAN | Elanco Animal Health Incorporated | $12.20B | Large cap | +41.03% |
| SN.L | Smith & Nephew plc | $12.20B | Large cap | −21.69% |
| EHC | Encompass Health Corporation | $11.85B | Large cap | −1.16% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $11.83B | Large cap | +24.24% |
| A1LG34.SA | Align Technology, Inc. | $11.51B | Large cap | +7.83% |
| DVA | DaVita Inc. | $11.41B | Large cap | +29.47% |
| ALGN | Align Technology, Inc. | $11.34B | Large cap | +10.11% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +137.67% |
| AFW.DE | Align Technology, Inc. | $11.31B | Large cap | −54.37% |
| TECH | Bio-Techne Corporation | $11.27B | Large cap | +28.12% |
| T1CH34.SA | Bio-Techne Corporation | $11.23B | Large cap | +23.42% |
| GMED | Globus Medical, Inc. | $11.14B | Large cap | +35.16% |
| DVAI34.SA | DaVita Inc. | $11.11B | Large cap | +15.68% |
| I1QV34.SA | IQVIA Holdings Inc. | $10.82B | Large cap | −67.19% |
| CYTK | Cytokinetics, Incorporated | $10.77B | Large cap | +109.29% |
| AXSM | Axsome Therapeutics, Inc. | $10.76B | Large cap | +76.67% |
| GKOS | Glaukos Corporation | $10.70B | Large cap | +98.13% |
| SMMT | Summit Therapeutics Inc. | $10.66B | Large cap | −49.14% |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +52.01% |
| KRYS | Krystal Biotech, Inc. | $10.54B | Large cap | +142.69% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +202.82% |
| BIO | Bio-Rad Laboratories, Inc. | $10.45B | Large cap | +31.26% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.44% |
| ABVX.PA | ABIVAX Société Anonyme | $10.42B | Large cap | +42.59% |
| MOH | Molina Healthcare, Inc. | $10.42B | Large cap | +13.96% |
| BIM.PA | bioMérieux S.A. | $10.40B | Large cap | −37.52% |
| UHS | Universal Health Services, Inc. | $10.40B | Large cap | −4.14% |
| ABVX | ABIVAX Société Anonyme | $10.29B | Large cap | +52.25% |
| RDY | Dr. Reddy's Laboratories Limited | $10.28B | Large cap | −14.66% |
| PRAX | Praxis Precision Medicines, Inc. | $10.28B | Large cap | +684.02% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +49.84% |
| HSIC | Henry Schein, Inc. | $10.21B | Large cap | +30.93% |
| U1HS34.SA | Universal Health Services, Inc. | $10.21B | Large cap | −10.02% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +265.05% |
| RHCPA.AX | Ramsay Health Care Limited | $10.16B | Large cap | +0.44% |
| PTGX | Protagonist Therapeutics, Inc. | $10.01B | Large cap | +164.75% |
| SRPT | Sarepta Therapeutics, Inc. | $2.00B | Small cap | +4.76% |
| GHRS | GH Research PLC | $1.99B | Small cap | +119.42% |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +9.98% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | $1.98B | Small cap | −2.43% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.97B | Small cap | +8.44% |
| SNDA | Sonida Senior Living, Inc. | $1.97B | Small cap | +57.21% |
| FLRY3.SA | Fleury S.A. | $1.97B | Small cap | +39.13% |
| ZYME | Zymeworks Inc. | $1.96B | Small cap | +88.54% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $1.95B | Small cap | −9.02% |
| LKFT | Lakefront Biotherapeutics NV | $1.94B | Small cap | −5.53% |
| SEPN | Septerna, Inc. | $1.93B | Small cap | +245.32% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +14.76% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.91B | Small cap | −26.29% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +18.72% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +800.59% |
| GXE.DE | Lakefront Biotherapeutics NV | $1.89B | Small cap | −44.50% |
| ALVO-SDB.ST | Alvotech SDB | $1.87B | Small cap | −34.75% |
| ASTH | Astrana Health, Inc. | $1.87B | Small cap | +25.66% |
| PSNL | Personalis, Inc. | $1.84B | Small cap | +267.02% |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −39.02% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.11% |
| VIR | Vir Biotechnology, Inc. | $1.81B | Small cap | +144.52% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +390.10% |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −18.51% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | $1.81B | Small cap | +52.14% |
| ETON | Eton Pharmaceuticals, Inc. | $1.80B | Small cap | +268.93% |
| ALVO | Alvotech | $1.80B | Small cap | −39.30% |
| 4540.T | Tsumura & Co. | $1.78B | Small cap | +9.38% |
| INSP | Inspire Medical Systems, Inc. | $1.77B | Small cap | −34.28% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +27.20% |
| ATT.ST | Attendo AB (publ) | $1.76B | Small cap | +75.11% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.74B | Small cap | −16.24% |
| FTRE | Fortrea Holdings Inc. | $1.74B | Small cap | +106.21% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +335.60% |
| AVLN | Avalyn Pharma Inc. | $1.69B | Small cap | +29.54% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +128.55% |
| 7716.T | Nakanishi Inc. | $1.68B | Small cap | +55.31% |
| CLARI.PA | Clariane SE | $1.67B | Small cap | −7.85% |
| SIA.TO | Sienna Senior Living Inc. | $1.65B | Small cap | +25.31% |
| ABSI | Absci Corporation | $1.65B | Small cap | +279.13% |
| 4DX.AX | 4DMedical Limited | $1.65B | Small cap | +652.94% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +580.25% |
| BCAX | Bicara Therapeutics Inc. | $1.63B | Small cap | +117.14% |
| 8129.T | Toho Holdings Co., Ltd. | $1.62B | Small cap | −22.82% |
| 8086.T | Nipro Corporation | $1.62B | Small cap | +6.42% |
| AGL | agilon health, inc. | $1.61B | Small cap | +178.58% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.61B | Small cap | +137.42% |
| ARDT | Ardent Health, Inc. | $1.59B | Small cap | −10.95% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.59B | Small cap | +12.48% |
| TYRA | Tyra Biosciences, Inc. | $1.59B | Small cap | +122.42% |
| OMCL | Omnicell, Inc. | $1.58B | Small cap | +0.39% |
| KMTS | Kestra Medical Technologies, Ltd. | $1.58B | Small cap | +51.92% |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +48.10% |
| LBRX | LB Pharmaceuticals Inc | $1.57B | Small cap | +182.08% |
| AAPG | Ascentage Pharma Group Internat | $1.57B | Small cap | −61.38% |
| NVAX | Novavax, Inc. | $1.56B | Small cap | +25.53% |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.55B | Small cap | −25.64% |
| AVBP | ArriVent BioPharma, Inc. | $1.55B | Small cap | +62.02% |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.53% |
| CNMD | CONMED Corporation | $1.53B | Small cap | −5.45% |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.14% |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.53B | Small cap | +18.84% |
| 6849.T | Nihon Kohden Corporation | $1.53B | Small cap | −5.62% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.51B | Small cap | +301.52% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.50B | Small cap | +83.48% |
| SDGR | Schrödinger, Inc. | $1.50B | Small cap | +2.30% |
| REPL | Replimune Group, Inc. | $1.49B | Small cap | +187.80% |
| AKTS | Aktis Oncology, Inc. | $1.48B | Small cap | +19.15% |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +197.55% |
| PYC.AX | PYC Therapeutics Limited | $1.48B | Small cap | +63.71% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +200.39% |
| AMBEA.ST | Ambea AB (publ) | $1.48B | Small cap | +32.95% |
| NOLA-B.ST | Nolato AB (publ) | $1.48B | Small cap | −8.30% |
| ENOV | Enovis Corporation | $1.48B | Small cap | −17.46% |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +14.00% |
| PAHC | Phibro Animal Health Corporation | $1.46B | Small cap | +13.43% |
| RDC.DE | Redcare Pharmacy NV | $1.46B | Small cap | −31.39% |
| AZTA | Azenta, Inc. | $1.45B | Small cap | +7.96% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +107.85% |
| ATEC | Alphatec Holdings, Inc. | $1.43B | Small cap | −41.10% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +96.83% |
| ANRO | Alto Neuroscience, Inc. | $1.42B | Small cap | +821.57% |
| GDS.PA | Ramsay Générale de Santé SA | $1.41B | Small cap | +11.00% |
| 4483.T | JMDC Inc. | $1.41B | Small cap | −18.41% |
| 3148.T | Create SD Holdings Co., Ltd. | $1.40B | Small cap | +3.09% |
| OMER | Omeros Corporation | $1.40B | Small cap | +343.22% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.40B | Small cap | +43.76% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +176.46% |
| F9L.F | Joincare Pharmaceutical Group Industry Co.,Ltd. | $1.39B | Small cap | −48.41% |
| 9627.T | Ain Holdings Inc. | $1.38B | Small cap | +4.41% |
| 3360.T | Ship Healthcare Holdings, Inc. | $1.37B | Small cap | +9.23% |
| P1RG34.SA | Perrigo Company plc | $1.37B | Small cap | −59.77% |
| VITR.ST | Vitrolife AB (publ) | $1.36B | Small cap | −31.27% |
| DRTS | Alpha Tau Medical Ltd. | $1.36B | Small cap | +357.94% |
| CHEMM.CO | ChemoMetec A/S | $1.35B | Small cap | −4.56% |
| UPR.L | Uniphar plc | $1.35B | Small cap | +4.35% |
| MNKD | MannKind Corporation | $1.34B | Small cap | +6.67% |
| PNTG | The Pennant Group, Inc. | $1.34B | Small cap | +55.24% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.52% |
| REG.AX | Regis Healthcare Limited | $1.32B | Small cap | −19.77% |
| AMN | AMN Healthcare Services, Inc. | $1.31B | Small cap | +63.90% |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +17.66% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −41.72% |
| SPI.L | Spire Healthcare Group plc | $1.30B | Small cap | +5.16% |
| CRON | Cronos Group Inc. | $1.29B | Small cap | +35.52% |
| CRON.TO | Cronos Group Inc. | $1.29B | Small cap | +34.72% |
| SPTX | Seaport Therapeutics, Inc. | $1.29B | Small cap | +25.15% |
| AORT | Artivion, Inc. | $1.29B | Small cap | −39.45% |
| NUTX | Nutex Health Inc. | $1.28B | Small cap | +110.14% |
| IMTX | Immatics N.V. | $1.26B | Small cap | +76.67% |
| ODTX | Odyssey Therapeutics, Inc. | $1.26B | Small cap | +59.74% |
| 4544.T | H.U. Group Holdings, Inc. | $1.26B | Small cap | +11.45% |
| RYM.AX | RYM FPO NZX [RYM] | $1.26B | Small cap | −28.42% |
| BIOG-B.ST | BioGaia AB (publ) | $1.25B | Small cap | +14.81% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.24B | Small cap | +217.21% |
| CERT | Certara, Inc. | $1.24B | Small cap | −24.70% |
| PRCT | PROCEPT BioRobotics Corporation | $1.24B | Small cap | −45.05% |
| 2175.T | SMS Co., Ltd. | $1.24B | Small cap | +56.85% |
| SANA | Sana Biotechnology, Inc. | $1.23B | Small cap | +22.39% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.16% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | $1.22B | Small cap | +34.73% |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +0.47% |
| 6523.T | PHC Holdings Corporation | $1.19B | Small cap | +59.08% |
| 4887.T | Sawai Group Holdings Co., Ltd. | $1.18B | Small cap | −12.23% |
| GDRX | GoodRx Holdings, Inc. | $1.17B | Small cap | −18.24% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +115.43% |
| STAA | STAAR Surgical Company | $1.17B | Small cap | −15.68% |
| USPH | U.S. Physical Therapy, Inc. | $1.15B | Small cap | −7.75% |
| TTALO.HE | Terveystalo Oyj | $1.15B | Small cap | −24.58% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.15B | Small cap | +27.68% |
| SVRA | Savara Inc. | $1.15B | Small cap | +78.34% |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.14B | Small cap | −34.83% |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +4.54% |
| JANX | Janux Therapeutics, Inc. | $1.14B | Small cap | −18.82% |
| T2DH34.SA | Teladoc Health, Inc. | $1.13B | Small cap | −23.05% |
| IVA.PA | Inventiva S.A. | $1.13B | Small cap | −14.58% |
| TDOC | Teladoc Health, Inc. | $1.12B | Small cap | −19.30% |
| SNZ.AX | Summerset Group Holdings Limited | $1.12B | Small cap | −32.53% |
| PHIL.MI | Philogen S.p.A. | $1.12B | Small cap | +2.12% |
| IRMD | IRADIMED CORPORATION | $1.11B | Small cap | +24.31% |
| SPH.WA | Sopharma AD | $1.11B | Small cap | −33.66% |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +7.19% |
| IVA | Inventiva S.A. | $1.11B | Small cap | +0.54% |
| 7476.T | AS ONE Corporation | $1.11B | Small cap | +2.10% |
| KURA | Kura Oncology, Inc. | $1.10B | Small cap | +77.65% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | $1.09B | Small cap | +36.80% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | $1.08B | Small cap | −0.90% |
| 006280.KS | GC Biopharma Corp. | $1.06B | Small cap | −1.88% |
| AVTX | Avalo Therapeutics, Inc. | $1.06B | Small cap | +110.00% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $1.04B | Small cap | +107.08% |
| CADL | Candel Therapeutics, Inc. | $1.04B | Small cap | +138.18% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −47.18% |
| QDEL | QuidelOrtho Corporation | $1.03B | Small cap | −45.57% |
| GUBRA.CO | Gubra A/S | $1.03B | Small cap | −2.92% |
| GXI.DE | Gerresheimer AG | $1.03B | Small cap | −33.73% |
| MEDCL.PA | MedinCell S.A. | $1.03B | Small cap | +40.14% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +48.57% |
| CLYM | Climb Bio Inc | $1.02B | Small cap | +619.35% |
| CSTL | Castle Biosciences, Inc. | $1.02B | Small cap | +70.15% |
| PCRX | Pacira BioSciences, Inc. | $1.00B | Small cap | +0.67% |
| 7730.T | Mani, Inc. | $997.86M | Small cap | +32.50% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | $997.09M | Small cap | −10.28% |
| GERN | Geron Corporation | $995.83M | Small cap | +9.15% |
| SLDB | Solid Biosciences Inc. | $982.18M | Small cap | +76.61% |
| DSGN | Design Therapeutics, Inc. | $981.28M | Small cap | +201.54% |
| ANNX | Annexon, Inc. | $976.33M | Small cap | +139.53% |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −37.62% |
| IMMX | Immix Biopharma, Inc. | $968.90M | Small cap | +589.05% |
| EUZ.DE | Eckert & Ziegler SE | $963.05M | Small cap | −23.06% |
| BVS | Bioventus Inc. | $961.74M | Small cap | +89.25% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | $958.89M | Small cap | +10.48% |
| VETO.PA | Vetoquinol SA | $958.31M | Small cap | −6.50% |
| OLMA | Olema Pharmaceuticals, Inc. | $954.60M | Small cap | +95.17% |
| HELP | Cybin D/B/A Helus Pharma | $951.24M | Small cap | +92.90% |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +52.91% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $934.98M | Small cap | −26.32% |
| NEU.WA | NEUCA S.A. | $930.51M | Small cap | +17.99% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $928.98M | Small cap | +60.46% |
| ACRS | Aclaris Therapeutics, Inc. | $928.83M | Small cap | +263.06% |
| DBV.PA | DBV Technologies S.A. | $928.30M | Small cap | +54.11% |
| 3046.T | JINS HOLDINGS Inc. | $921.19M | Small cap | −21.01% |
| CBLL | CeriBell, Inc. | $919.16M | Small cap | +109.35% |
| PHN.MI | Pharmanutra S.p.A. | $911.23M | Small cap | +71.93% |
| B2RK34.SA | Bruker Corporation | $906.52M | Small cap | +63.27% |
| 4587.T | PeptiDream Inc. | $902.75M | Small cap | −28.26% |
| SGP | SpyGlass Pharma, Inc. | $889.72M | Small cap | +0.76% |
| SYNSAM.ST | Synsam AB (publ) | $889.34M | Small cap | +9.18% |
| 7780.T | Menicon Co., Ltd. | $887.42M | Small cap | +57.22% |
| ANL | Adlai Nortye Ltd. | $884.83M | Small cap | +737.80% |
| TBPH | Theravance Biopharma, Inc. | $883.14M | Small cap | +23.45% |
| MCAP.ST | MedCap AB (publ) | $878.41M | Small cap | −8.86% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +97.74% |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +10.83% |
| SIBN | SI-BONE, Inc. | $866.59M | Small cap | +21.74% |
| AVR | Anteris Technologies Global Corp. | $865.37M | Small cap | +140.27% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +14.75% |
| INMD | InMode Ltd. | $864.89M | Small cap | +3.16% |
| AVR.AX | Anteris Technologies Global Corp. | $863.83M | Small cap | +102.52% |
| 4694.T | BML, Inc. | $862.01M | Small cap | +7.64% |
| DYVOX.ST | Dynavox Group AB (publ) | $860.56M | Small cap | −39.04% |
| SFL.MI | Safilo Group S.p.A. | $856.14M | Small cap | +24.24% |
| COLL | Collegium Pharmaceutical, Inc. | $851.55M | Small cap | −29.15% |
| OXB.L | Oxford Biomedica plc | $850.70M | Small cap | −8.62% |
| FDMT | 4D Molecular Therapeutics, Inc. | $850.21M | Small cap | +133.23% |
| SLN | Silence Therapeutics plc | $849.65M | Small cap | +170.16% |
| AHG | Akso Health Group | $843.17M | Small cap | −44.40% |
| HSTM | HealthStream, Inc. | $841.53M | Small cap | +4.49% |
| GNFT.PA | Genfit S.A. | $836.50M | Small cap | +293.99% |
| AMS.L | Advanced Medical Solutions Group plc | $835.93M | Small cap | +37.58% |
| PHAR | Pharming Group N.V. | $833.06M | Small cap | −19.75% |
| APOTEA.ST | Apotea AB | $828.96M | Small cap | −29.63% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $819.46M | Small cap | +47.91% |
| ARJO-B.ST | Arjo AB (publ) | $817.68M | Small cap | −17.06% |
| NGNE | Neurogene Inc. | $817.26M | Small cap | +104.40% |
| ACHV | Achieve Life Sciences, Inc. | $817.05M | Small cap | +146.83% |
| AURA | Aura Biosciences, Inc. | $810.97M | Small cap | +19.94% |
| WELL.TO | WELL Health Technologies Corp. | $802.96M | Small cap | −10.70% |
| EIQ.AX | Echo IQ Limited | $795.46M | Small cap | +653.66% |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +710.87% |
| SNT.WA | Synektik Spólka Akcyjna | $783.39M | Small cap | +53.56% |
| DRUG | Bright Minds Biosciences Inc. | $779.96M | Small cap | +90.62% |
| VREX | Varex Imaging Corporation | $779.74M | Small cap | +62.28% |
| NVCT | Nuvectis Pharma, Inc. | $777.72M | Small cap | +298.92% |
| UU8.F | Neurogene Inc. | $773.41M | Small cap | +157.60% |
| 001067.KS | JW Pharmaceutical Corporation | $766.24M | Small cap | −21.42% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −3.50% |
| ALLO | Allogene Therapeutics, Inc. | $749.72M | Small cap | +87.07% |
| MNPR | Monopar Therapeutics Inc. | $747.47M | Small cap | +264.30% |
| AHCO | AdaptHealth Corp. | $745.58M | Small cap | −40.63% |
| TECX | Tectonic Therapeutic, Inc. | $737.21M | Small cap | +53.48% |
| SOPH | SOPHiA GENETICS SA | $736.36M | Small cap | +150.72% |
| 4534.T | Mochida Pharmaceutical Co., Ltd. | $735.78M | Small cap | +8.68% |
| CTMX | CytomX Therapeutics, Inc. | $734.32M | Small cap | +68.50% |
| D2OC34.SA | Doximity, Inc. | $734.04M | Small cap | −64.74% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $725.40M | Small cap | +245.67% |
| DHT-UN.TO | DRI Healthcare Trust | $723.54M | Small cap | +28.36% |
| OCS | Oculis Holding AG | $719.64M | Small cap | −27.15% |
| ASMB | Assembly Biosciences, Inc. | $718.32M | Small cap | +32.72% |
| 4588.T | Oncolys BioPharma Inc. | $716.01M | Small cap | +526.71% |
| ZVRA | Zevra Therapeutics, Inc. | $714.98M | Small cap | +28.63% |
| PHAT | Phathom Pharmaceuticals, Inc. | $711.93M | Small cap | −25.15% |
| PHR | Phreesia, Inc. | $711.64M | Small cap | −62.09% |
| SSII | SS Innovations International, Inc. | $711.37M | Small cap | −49.14% |
| XOMA | XOMA Royalty Corp | $710.16M | Small cap | +18.95% |
| 9267.T | Genky DrugStores Co., Ltd. | $706.67M | Small cap | −19.42% |
| C2RS34.SA | CRISPR Therapeutics AG | $704.20M | Small cap | −0.08% |
| BHVN34.SA | BIOHAVEN LTDDRN | $694.78M | Small cap | −18.03% |
| 7575.T | Japan Lifeline Co., Ltd. | $694.70M | Small cap | +12.56% |
| GUD.TO | Knight Therapeutics Inc. | $692.32M | Small cap | +49.08% |
| PROK | ProKidney Corp. | $690.59M | Small cap | −26.38% |
| AGMB | AgomAb Therapeutics NV | $690.46M | Small cap | −4.30% |
| DHT-U.TO | DRI Healthcare Trust | $690.34M | Small cap | +27.68% |
| GMRS | GMR Solutions Inc. | $686.08M | Small cap | −9.16% |
| GYRE | Gyre Therapeutics, Inc. | $682.86M | Small cap | −18.54% |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −16.33% |
| OABI | OmniAb, Inc. | $677.52M | Small cap | +185.89% |
| EVT.DE | Evotec SE | $675.17M | Small cap | −44.85% |
| PRME | Prime Medicine, Inc. | $672.91M | Small cap | +5.40% |
| EVO | Evotec SE | $671.69M | Small cap | −47.06% |
| TLRY | Tilray Brands, Inc. | $671.39M | Small cap | −66.04% |
| TLRY.TO | Tilray Brands, Inc. | $670.30M | Small cap | +237.44% |
| CU6.AX | Clarity Pharmaceuticals Ltd | $669.65M | Small cap | −27.91% |
| CRMD | CorMedix Inc. | $667.20M | Small cap | −37.65% |
| LBIRD.PA | Lumibird SA | $664.75M | Small cap | +58.39% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.